ArticleFrontiers in transplantation2022

Neoadjuvant Therapy With Cabozantinib as a Bridge to Liver Transplantation in Patients With Hepatocellular Carcinoma (HCC): A Case Report.

Hiral Bhardwaj et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.